Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model

Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury

(2010) So-Young Hwang et al.   GLIA

Metabolomic profiling of uremic solutes in CKD patients

(2010) Takafumi Toyohara et al.   HYPERTENSION RESEARCH

Metabolomic Profiling of Anionic Metabolites by Capillary Electrophoresis Mass Spectrometry

(2009) Tomoyoshi Soga et al.   ANALYTICAL CHEMISTRY

Advances in the pathogenesis and treatment of polycystic kidney disease

(2009) Vishal Patel et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Renal Volume, Renin-Angiotensin-Aldosterone System, Hypertension, and Left Ventricular Hypertrophy in Patients with Autosomal Dominant Polycystic Kidney Disease

(2009) R. W. Schrier   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

SLCO4C1 Transporter Eliminates Uremic Toxins and Attenuates Hypertension and Renal Inflammation

(2009) T. Toyohara et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Asymmetric Dimethylarginine and Lipid Peroxidation Products in Early Autosomal Dominant Polycystic Kidney Disease

(2008) Dan Wang et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

(2008) Jan T Kielstein et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease

(2008) Victoria Cachofeiro et al.   KIDNEY INTERNATIONAL

What is new in uremic toxicity?

(2008) Raymond Vanholder et al.   PEDIATRIC NEPHROLOGY